Liquid Biopsy: Current advancements in clinical practice for bladder cancer [0.03%]
液体活检：临床实践中膀胱癌当前进展
Felice Crocetto,Ugo Amicuzi,Michele Musone et al.
Felice Crocetto et al.
Bladder cancer is the ninth most common malignancy worldwide, with two clinically distinct forms: non-muscle-invasive disease, characterized by high recurrence and excellent long-term survival, and muscle-invasive disease, associated with p...
The role of circulating tumor cells in shaping the future of early-stage lung cancer treatment: a clinical point of view [0.03%]
循环肿瘤细胞在塑造早期肺癌治疗未来方面的角色：临床观点
Filippo Lococo,Jessica Evangelista,Carolina Sassorossi et al.
Filippo Lococo et al.
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood [0.03%]
新型液体活检应用：外周血循环生物标志物探索的全面方法学研究
Caterina De Rosa,Luisa Amato,Annalisa Ariano et al.
Caterina De Rosa et al.
The liquid biopsy (LB) represents a minimally invasive method for cancer screening that has been introduced in clinical practice for over a decade and that can accelerate treatment response assessment. LB allows the analysis of tumor cells ...
Tumor-infiltrating lymphocytes in melanoma: diagnostic and prognostic implications from biopsy to circulation [0.03%]
黑色素瘤中的肿瘤浸润淋巴细胞：从活检到外周血的诊断和预后意义
Hussain Noorwali
Hussain Noorwali
Melanoma is a highly aggressive skin cancer that arises from melanocytes and presents considerable clinical challenges due to its strong metastatic capacity and ability to evade the immune system. Tumor-infiltrating lymphocytes (TILs) refle...
Shivahamy Maheswaran,Roberto Borea,Diego de Miguel Perez et al.
Shivahamy Maheswaran et al.
Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directions [0.03%]
基于血液和尿液的前列腺癌生物标志物：当前进展、临床应用及未来方向
Felice Crocetto,Michele Musone,Stefano Chianese et al.
Felice Crocetto et al.
Prostate cancer (PCa) is one of the most prevalent malignancies in men, characterized by high clinical and molecular heterogeneity. Despite the widespread use of prostate-specific antigen (PSA) for diagnosis and monitoring, its limited spec...
Liquid biopsy as a potential tool for diagnosis and clinical monitoring of cutaneous and uveal melanoma [0.03%]
液体活检在皮肤和葡萄膜黑色素瘤诊断及临床监测中的潜在应用价值研究
Letícia Silva Ferraz,Alana Silveira Oliveira Souza,Tiago Rodrigues et al.
Letícia Silva Ferraz et al.
Melanoma is the most aggressive type of skin cancer, characterized by high metastatic potential and high mortality rates. Currently, diagnosis and mutational status assessment involves the excisional tissue biopsy followed by anatomopatholo...
Utility of combined solid and liquid biopsy for molecular profiling in lung adenocarcinoma: Insights from a real-world case [0.03%]
液体和组织活检联合检测在肺癌分子分型中的应用价值——一例真实世界病例的启示
Bharat Bhosale,Gunj Bafna,Paridhy Vanniya Subramanyam et al.
Bharat Bhosale et al.
Lung adenocarcinoma is a subtype of NSCLC that is often associated with poor prognosis. We present a case of metastatic lung adenocarcinoma in which comprehensive genomic profiling using both solid and liquid biopsies was employed to monito...
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors [0.03%]
国际液体活检学会(ISLB)关于实体瘤循环肿瘤DNA检测最低要求的共识声明
Nicola Fusco,Konstantinos Venetis,Francesco Pepe et al.
Nicola Fusco et al.
Circulating tumor DNA (ctDNA) testing has transformed precision oncology by enabling the non-invasive detection of actionable mutations. To facilitate broader clinical adoption and improve testing accuracy, standardized quality criteria mus...
The impact of liquid biopsy in breast cancer: Redefining the landscape of non-invasive precision oncology [0.03%]
液体活检在乳腺癌中的影响：重新定义非侵入性精准肿瘤学的格局
Shaivy Malik,Sufian Zaheer
Shaivy Malik
Breast cancer (BC) remains a leading cause of morbidity and mortality among women worldwide, necessitating the development of innovative diagnostic and monitoring strategies. Liquid biopsy (LB), a minimally invasive approach that analyzes c...